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reasons for self-medication, factors that influenced the choice of drug and source of 
drug. Results: People of all socio-demographic categories practice self-medication. 
A total of 76.8% of the respondents indulged in self-medication practices. Of which, 
33.0% used the medication inappropriately. The most frequently self-diagnosed ill-
nesses or symptoms of illnesses were: GI illnesses, cough/cold and headache/fever. 
Of these illnesses, more than 35% were less than 24 hours duration and nearly 80% 
less than seven days duration of illness. The reasons given by respondents for self-
diagnosis and self-medication were non-seriousness of the illnesses, for emergency 
use and prior experience about the illness with similar symptoms (39.7%) and even 
advice of non-physician health professional (33.5%). Whatever the duration of ill-
nesses and reasons for self-diagnosis, nearly 65% requested drugs by mentioning 
the names of the drugs and more than one-fifth by telling the symptoms of their 
illnesses. Requests for analgesics/antipyretics were very high (60%) followed by anti-
microbial drugs (40%) for all reported illness. Drug requested mostly in other con-
ditions include cold/cough suppressants, Gastro Intestinal drugs and very low for 
ORS. ConClusions: The level of inappropriate drug use denotes self-medication 
as an unhealthy option, and it therefore, should be discouraged.
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objeCtives: The study aimed to document the duration of tuberculosis (TB) treat-
ment, and its relationship with the characteristics of the patients. Methods: This 
prospective follow-up cohort study was conducted at the chest clinic of Penang 
General Hospital between March 2010 and February 2011. Medical records and 
TB notification forms of all new smear positive pulmonary tuberculosis (PTB) 
patients, who were diagnosed during the study period, were reviewed to obtain 
socio-demographic and clinical data. Based on the standard guidelines, the normal 
benchmarks of treatment duration for the intensive- and continuation phase of 
TB treatment were taken as 2 and 4 months, respectively. A patient in whom the 
clinicians decided to extend the intensive phase (IP) for ≥ 2 weeks was categorized 
as a case of prolonged IP. The same criterion applied for the continuation phase 
(CP) of the treatment. Results: Out of the total 336 patients, 261 completed the 
IP of the treatment. Subsequently, 226 completed the CP. The average duration of 
TB treatment (n = 226) was 8.19 (SD 1.65) months. 49.4% (129 out of 261) patients 
completed the IP in 2 months, whereby only 37.6% patients (85 out of 226) com-
pleted the CP of the treatment in 4 months. In multiple logistic regression analysis, 
being a smoker, body mass index less than normal and a history of ≥ 4 weeks 
cough were the predictors of longer duration of the IP, while diabetes mellitus and 
presence of lung cavities were the only predictors of longer duration of the CP of 
the treatment. ConClusions: The average duration of treatment in new smear 
positive PTB patients was longer than the targets set by World Health Organization. 
There is lacking a uniform international criterion to evaluate how well National 
Tuberculosis Program of Malaysia has performed in terms of managing duration 
of treatment in PTB patients.
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objeCtives: The use of bacterial lysates as an immuno-modulator to boost immu-
nological response in patients with Recurrent Respiratory Tract Infections and its 
effects on the attack frequency of respiratory infection have been widely debated. 
We aimed to conduct our meta-analysis on the effect of bacterial lysates plus rou-
tine care versus routine care only on the attack frequency of respiratory infection 
in patients with Recurrent Respiratory Tract Infections. Methods: We performed a 
systematic review of articles published from Jan 1, 2000 to Nov 10, 2013 by searching 
PubMed, Embase, Cochrane Central Register of Controlled Trials, and Wanfang and 
China National Knowledge Infrastructure. We included all randomised trials that 
compared outcomes between patients with Recurrent Respiratory Tract Infections 
receiving bacterial lysates plus routine care with those receiving routione care only. 
Eligible studies, determined by consensus with predefined criteria, were reviewed 
and data were extracted onto a standard form. We combined data to assess the 
primary outcome of attack frequency of respiratory infection using the DerSimonian 
and Laird random effects model. Results: Our search identified 128 reports, of 
which twelve studies met our inclusion criteria and were included in our meta-anal-
ysis. Analysis of the 12 randomised trials (959 patients) that reported an outcome 
on the attack frequency of respiratory infection showed that patients assigned to 
bacterial lysates plus routine care had a 2.942 reduction in respiratory tract infec-
tions compared to those assigned to routine care only (Weighted Mean Difference 
-2.942, 95% CI -3.600, -2.284). ConClusions: Bacterial lysates are associated with a 
decreased risk of respiratory tract infections in patients with Recurrent Respiratory 
Tract Infections. Further studies are needed to identify the causes of respiratory 
tract infections and to assess whether the attack frequency of respiratory infection 
differs with varying treatments of bacterial lysates.
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wide [Stage I(n= 858): 0.906(0.006); Stage II(n= 1,091): 0.912(0.005); Stage III(n= 119): 
0.857(0.018); Stage IV(n= 13): 0.780(0.071)]. EQ-5D was not significantly different 
by 4-stage disease severity but showed a trend of deterioration in Stage III and 
IV. In the post-hoc analysis, COPD patients were divided into two-stage groups 
[group 1: Stage I and II; group 2: Stage III and IV]. In this analysis, 2-stage sever-
ity had a negative association with utility(p= 0.0009). ConClusions: The results 
demonstrate that COPD impaires utility and shows a relationship between utility 
and COPD disease severity in Korea.
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objeCtives: The burden of COPD is increasing in Korea.Health-realted quality 
of life among COPD patients should be considered. Few national strategies to 
prevent and manage COPD have been intervened. In this study, we investigate 
the factors associated with COPD patients’ quality of life. Methods: Data of 
Korean National Health and Nutrition Examination Survey(KNHANES) 2007-2012 
were used. Multivariate regression anaysis was employed. Demographic variables 
(e.g. sex, age), socioeconomic status(SES) variables including education, insurance 
type, comorbidities(e.g. hypertension, diabetes, depressive disorder, cancer), sever-
ity of COPD, smoking were considered as independent variables. Results: We 
found that female(beta= -0.0387, p< 00001), age(beta= -0.0021,p< 0.0001), Medical 
aid bebeficieries(beta= -0.1001,p< 0.0001) showed a significantly lower score of 
EQ5D index. Mild(beta= 0.2001, p< 0.0001), moderate(beta= 0.1982, p< 0.0001), 
severe(beta= 0.1765, p< 0.0001) had significatly higher scores compared to that 
of very severe satge(GOLD IV). Education level also an important factor. Lower 
level of education(graduation from middle shcool or less) showed a negative 
association with EQ5D index score. Depression among comorbidities significantly 
worsened the quality of life of COPD paitents(beat= -0.7420, p< 0.0001). Smoking 
status(current smoker, ex-smoker, non-skmoker) did not show a significant dif-
ference. ConClusions: Socio-economic status of COPD patients including sex, 
age, edication level and insurance type, were important factors related to the 
health-related quality of life. After controlling these factors, severe and depressive 
COPD patients reported their quality of life was significantly worsened. Strategies 
for COPD prevention and management should be developed and implemented. 
Improvement of health-related quality of life in COPD can be considered as an 
index of goals to achieve.
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objeCtives: COPD is known as a disease with irreversible progress but 
preventable and managable. In Korea, COPD was ranked 12 with 242 DALYs 
(per 100,000) following diabetes(970 DALYs), cerebrovascular diseases(937DALYs) 
and asthma(709 DALYs). Health-related quality of life in COPD patients has not 
been investigated in Korea. Methods: Data of Korean National Health and 
Nutrition Examination Survey(KNHANES) 2007-2012 were used. According to 
the GOLD criteria, we classified COPD patients into I-IV grades. EQ-5D index 
score were analysed by the severity of COPD and Comorbidities. Wilcoxon 
rank-sum test were used to compare quality of liife in COPD patients with 
that of the general population. SAS 9.3 version was used for analysis. Results: 
Utility score for the general population was 0.9291±0.1320 while COPD patients 
were scored 0.9042±0.1478 showing a significant difference(p< 0.0001). 
Comorbidities demosntrated a significant impact on the quality of life among 
COPD patients. Patients with hypertension(0.8863±0.1574), diabetes 
(0.882831±0.169179), cancer(0.8675±0.1691), and depression(0.8089±0.1784) showed 
a significantly lower utility score that those without comorbidities(p< 0.0001, 
p= 0.0042, p< 0.0001, p= 0.0687, respectively). According to the severity, 
mild(0.905754±0.140629) and moderate(0.9090±0.1465) COPD patients had a similar 
EQ5D index score. However, severe(0.8722±0.1724) and very severe(0.6816±0.2705) 
stages showed a significantly lower quality of life. We also found that diagnosed 
rate among COPD patients was only 2.96%. ConClusions: As severity of COPD 
has shown a great impact on quality of life, preventable strategy and management 
should be developed. Especially early diagnosis and early detection will be the first 
step to take for COPD management in South Korea. To do so, interdisciplenary 
approach should be made.
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objeCtives: To determine the pattern of self-medication among the people of 
region and to evaluate the factors associated with self-medication. Methods: 
The data for this study was collected by the survey method in community phar-
macies. This was done by directly approaching the consumer for self-medication 
during the study period for their own use or as messengers for others. The struc-
tured research instrument was a simplified questionnaire, which sought informa-
tion on demographic background and self-medication practices. The elicited data 
include demography, use of drug without doctor’s prescription, type of drug used, 
